PRECISION-GI™
Superior Endoscopic Biopsy
Our Vision
We seek to ensure that endoscopic biopsies can always achieve a definitive diagnosis to enable optimal and timely cancer treatment.
In order to improve the endoscopic experience for both the endoscopist and the patient, we aim to provide:
- Faster, more efficient biopsy procedures
- Highly consistent results, regardless of physician skill level
- Easily replicable method to achieve a definitive diagnosis for histological and genetic testing
Introducing Precision-GI™
Limaca Medical develops PRECISION-GI™ – A motorized EUS biopsy device designed to consistently obtain high-quality core tissue for reliable histology and molecular analysis.
- FDA 510(k) cleared
- FDA Breakthrough Device designated
- Commercially launched in the United States
How PRECISION-GI™ is Improving the Standard of Care
Manual EUS needles represent the traditional standard of current endoscopic biopsy devices.
See how the manual standard compares to Precision-GI™:
PRECISION-GI™
Designed to meet or exceed
all customer needs
- Automated, no user-dependency
- 1 Pass, 2–3 controlled cores obtained
- Far shorter procedure
- Precise control
- Excellent tissue quality
STANDARD OF CARE
Current endoscopic
biopsy devices
- Manual tool, user-dependent
- 2–5 Passes, 30–50 stabs
- Time consuming
- Imprecise
- Fragmented, inconsistent sample quality
Clinical Evidence
Precision-GI™ has been evaluated in more than 60 EUS-guided biopsy procedures
performed at leading international endoscopy centers.
The device demonstrated consistent performance across a broad range of clinical
scenarios, including pancreatic masses, liver lesions, and peri-GI targets.
Physician Feedback
“I am excited to partner with Limaca to help bring an amazing automated, 20-gauge EUS biopsy needle to the USA. We biopsied everything from lymph nodes to bile duct and pancreas masses successfully. Hackensack Meridian Health and Hackensack University Medical Center are leading the way to precise biopsy results with cutting-edge endoscopic capabilities.”
Dr. Rosario Ligresti
Chief of Gastroenterology, Hackensack University Medical Center Chief of Gastroenterology and Interventional Endoscopy, Hackensack Meridian Health
“The procedure with Precision GI is super easy for the physician, and the results after just one pass are phenomenal. The core sample is not fragmented or bloody. It’s very clear, it’s impressive. The quality of the biopsy tissue is amazing. Having used core needles for many years, I haven’t had samples that are not bloody, especially, for example, with the liver. This will be very revolutionary for quality of tissue overall.”
Dr. Carlos Robles-Medranda
Head of Endoscopy Service, Ecuadorian Institute of Digestive Diseases (IECED), Guayaquil, Ecuador Director, Pentax Training Center Ecuador (PTCE)
“Precision-GI™ is an automated, motorized endoscopic biopsy product that has the potential to improve our biopsy results for the evaluation of gastrointestinal malignancies… Our field is driving toward patient-centric individualized cancer therapy, known as Precision Medicine.”
Dr. Seth A. Gross
Clinical Chief, Division of Gastroenterology and Hepatology, NYU Langone Health.
“The Limaca device was very simple and intuitive to use. This device standardizes the FNB process and takes out the variability among endoscopists to acquire adequate tissue samples.”
Dr. Mohamad Eloubeidi
Director of Endoscopy, Regional Medical Center (RMC) President, Alabama Gastroenterology Society
“I used the Limaca EUS-guided needle in a variety of pancreatic masses and one EUS-guided liver biopsy. The needle performed flawlessly. It passed through the endoscope easily, precise lesion puncture and very large core tissue specimens acquired.”
Dr. Isaac Raijman
Therapeutic Endoscopist & Gastroenterologist Clinical Associate Professor of Medicine, Baylor College of Medicine Texas International Endoscopy Center / TDDC Houston
Limaca Team
Our Partners
Latest Updates
Limaca Medical was featured in the latest Innovation Supplement of CUTTING EDGE magazine, a special project on Haaretz.com under “Haaretz Labels”.
This significant milestone further strengthens Limaca’s operational and quality infrastructure and joins the company’s FDA clearance, reinforcing our commitment to the highest standards of quality, safety, and regulatory excellence.
Dr. Irit Yaniv is a highly respected leader in the MedTech and innovation ecosystem, with more than 25 years of experience spanning executive management, venture capital, and global business development.